Valeant Kickback Case Puts Skilling To Test In 2nd Circ.

The Second Circuit pondered Monday whether nearly $10 million of undisclosed payments from a pharmacy CEO to a Valeant Pharmaceuticals executive rose to the level of criminal bribes or kickbacks under...

Already a subscriber? Click here to view full article